After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ROIV belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Roivant Sciences Ltd is $7.48B. A total of 5.5 million shares were traded on the day, compared to an average of 5.17M shares.
In the most recent transaction, Venker Eric sold 434,478 shares of ROIV for 10.82 per share on Mar 24 ’25. After the transaction, the President & COO now owns 1,127,290 company shares. In a previous transaction on Mar 20 ’25, Venker Eric sold 315,522 shares at 11.06 per share. ROIV shares that President & COO owns now total 959,457.
Among the insiders who bought shares, Venker Eric acquired of 650,000 shares on Mar 20 ’25 at a per-share price of $10.95. In another insider transaction, Venker Eric bought 100,000 shares at $11.11 per share on Mar 20 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ROIV has a high of $13.06 and a low of $9.96.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ROIV’s latest balance sheet shows that the firm has $2.06B in Cash & Short Term Investments as of fiscal 2022. There were $283.89M in debt and $184.37M in liabilities at the time. Its Book Value Per Share was $7.21, while its Total Shareholder’s Equity was $2.06B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ROIV is Buy with a score of 4.80.
